Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
You’ll instantly connect to the latest in global medtech developments with industry news, trends, deals, product developments, opinions, analysis, and context behind the headlines and more – all available at your fingertips.
Create your business-building strategy with Medtech Insight. Get the latest medical technology news and expert opinion on product developments, investment trends, deals, and shifts in industry dynamics, gaining insight into the evolving breakthrough medical technologies that will impact the industry. Plus, keep on top of regulatory changes and policy issues to see how these will impact the industry. Stay in touch with what your competitors are up to with news about manufacturing and approvals.
How it helps
Medtech Insight gives you quality news and insight into medical technologies in surgical, orthopedic, cardiovascular, and other markets.
How it works
As a subscriber, you’ll enjoy any-time, any-device access to the industry’s critical thinkers and opinion leaders. You’ll also receive access to Medtech Insight trackers, which monitor M&A and venture capital financing deals, product approvals, global regulatory guidance documents, US legislation, and US FDA warning letters.
Global content from trusted experts
More than a dozen experienced journalists and analysts based in Europe, US, and Asia bring you real-time analysis, news and opinion across the medtech landscape – covering regulatory, product and company developments.
Medtech Insight
By Sue Darcey 13 Nov 2019
US Democratic Sens. Elizabeth Warren of Massachusetts and Patty Murray of Washington State recently sent a letter to FDA officials Brett Giroir and Jeff Shuren that raises doubts about a planned bill calling for a progressive approval pathway for medical devices.
Topic FDA Policy and regulation
Medtech Insight
By Sue Darcey 13 Nov 2019
While a government agency shutdown due to lack of agreement between Congress and the Trump administration over funding for the US Food and Drug Administration and other federal agencies seems less likely this year than last, the FDA will still have carry out its 2020 mission in the short term on 2019 continuing resolution funding – probably through December – legislative experts say.
Topic FDA Policy and regulation
Medtech Insight
By Catherine Longworth 08 Nov 2019
With a new CEO at its helm, Laboratory for Advanced Medicine is preparing to take on the cancer-diagnostics market. Former AncestryDNA executive Kenneth Chahine has joined the company as it plans to drive global commercialization of its artificial intelligence liquid biopsy pipeline.
Topic Cancer Company analysis
Medtech Insight
By Ferdous Al-Faruque 08 Nov 2019
Medtronic’s director of quality sterilization and microbiology, Phil Cogdill, sat down with Medtech Insight to talk about setting new ethylene oxide (EtO) standards and what his takeaways were from the first day of a US FDA meeting to understand how to mitigate potential product shortages from closures of EtO sterilization facilities. Check out our podcast here.
Topic FDA
Medtech Insight
By Marion Webb 01 Nov 2019
Already used by tens of millions of consumers, voice assistants such as Amazon's Alexa are increasingly making their way into hospitals and health organizations. This article outlines multiple use cases where voice is deployed in health systems today, while offering expert insights on trends, opportunities and challenges in this growing space.
Topic Medtech
Medtech Insight
31 Oct 2019
Watch this Informa Pharma Intelligence webinar recording for insights into the revolution of digital health including the latest trends, current and future opportunities, and regulatory efforts and risks. Experts from the medical devices and pharmaceuticals industries present crucial information about the continuing evolution of today’s digital health landscape.
Topic Medtech Digital Health
Medtech Insight
25 Oct 2019
Stay aware of key developments and trends in US Medicare and understand their impact on the medtech industry with Medtech Insight. This article pack contains the latest US Medicare updates and late-stage developments.
Topic Medtech
Medtech Insight
25 Oct 2019
Don’t miss a beat with updated coverage of what’s happening with medtech and the US CMS with this article pack. Medtech Insight delivers vital, current news and insights.
Topic Medtech Policy and regulation
Medtech Insight
07 Oct 2019
On the heels of the July 2019 US presidential executive order to advance kidney health, companies like Paragonix have unveiled new technologies aimed at doing just that. Medtech Insight takes you inside what the company has in store.
Topic Medtech
Medtech Insight
07 Oct 2019
Since a presidential executive order to advance kidney health was signed in July of 2019, Medtech Insight has been tracking the subsequent developments in US kidney healthcare, noting an uptick in hemodialysis interest and new payment models around renal disease.
Topic Medtech
Medtech Insight
By Shawn M. Schmitt 23 Aug 2019
US FDA Compliance Branch directors Gina Brackett and Melissa Michurski shed light on the agency's use of regulatory meetings. The FDA has been pulling enforcement punches in recent years, relying more on holding the face-to-face meetings than sending warning letters.
Topic Policy and regulation
Medtech Insight
By Amanda Maxwell 23 Aug 2019
The European Commission updates its rolling plan on progress with key document and structures toward implementation of the new medtech regulations every few months. What is new and what is still to come this year?
Medtech Insight
By Shawn M. Schmitt 14 Aug 2019
Phil Pontikos, who is also the US agency's national device expert, explains how device-makers can avoid running afoul of the FDA's rules and expectations for sterilization activities.
Topic FDA
Medtech Insight
By Sue Darcey 14 Aug 2019
The US Medicare agency has been scrutinizing two new devices that have generated some buzz within the industry for pass-through payment status under its proposed 2020 Outpatient Prospective Payment System (OPPS) rules. The devices are Procept BioRobotic’s AquaBeam System for removal of prostate tissue in men with urinary tract symptoms, and Boston Scientific’s Eluvia drug-eluting stent for treatment of peripheral artery disease.
Topic Medtech
Medtech Insight
06 Aug 2019
US FDA says as artificial intelligence and machine learning offer new opportunities to improve patient care, the agency hopes to encourage innovation by developing a draft guidance on the issue for sponsors. It also released a discussion paper outlining key issues it wants feedback on from industry and other key stakeholders.
Topic FDA Digital Health Medtech
Medtech Insight
13 Nov 2019
Medtech Insight
12 Nov 2019
Medtech Insight
12 Nov 2019
Medtech Insight
12 Nov 2019
Medtech Insight
12 Nov 2019
Medtech Insight
12 Nov 2019
Medtech Insight
11 Nov 2019
Medtech Insight
11 Nov 2019
Medtech Insight
11 Nov 2019
Medtech Insight
08 Nov 2019
Medtech Insight
08 Nov 2019
Medtech Insight
08 Nov 2019
Medtech Insight
08 Nov 2019
Medtech Insight
08 Nov 2019
Medtech Insight
07 Nov 2019
Amanda specializes in
+35 year(s) experience
Neena specializes in
+32 year(s) experience
Ian specializes in
+31 year(s) experience
Get a window into what the leading players across the biopharma, medtech, and diagnostics industries are thinking, as well as important insight into what your competitors are doing. Build your strategy with In Vivo.
In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.
Looking for more products Product Finder
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
